Myelomatous meningitis.

Myelomatous meningitis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Myelomatous meningitis. Abstract Text:

Marc C Chamberlain,Michael Glantz,

BACKGROUND: The most frequent nervous system complications of multiple myeloma are peripheral neuropathy and epidural spinal cord compression. Myelomatous meningitis (MM) has been considered rare. The current study was performed to characterize the clinical presentation, treatment, and outcome of MM. METHODS: The study was a case series of 14 patients with cerebrospinal fluid (CSF)-positive MM who were treated at a tertiary care university medical center. RESULTS: Fourteen patients with advanced multiple myeloma were treated with involved-field radiotherapy (to the brain in 5 patients and the spine in 6 patients) and intra-CSF chemotherapy (ventricular in 10 patients and lumbar in 4 patients). The best response to treatment included 6 partial responses and 8 patients with progressive disease. The median duration of response was 2.5 months (range, 0-6 months). Cause of death was progressive neurologic disease in 6 patients, combined systemic and neurologic disease in 6 patients, and systemic disease progression in 2 patients. CONCLUSIONS: MM is rare and morbid entity (6-month neurologic disease progression-free survival rate of 7%), and appears to be no more responsive to treatment than solid tumor carcinomatous meningitis. Cancer 2008. (c) 2008 American Cancer Society.

Myelomatous meningitis. Publishing Authors By Initials

MC Chamberlain,M Glantz,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Myelomatous meningitis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer

VOLUME: 112

Page Numbers: 1562-7

Journal Abbreviation: Cancer

ISSN: 0008-543X

DAY: 1

MONTH: Apr

YEAR: 2008

Myelomatous meningitis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 374236

Myelomatous meningitis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Myelomatous meningitis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Myelomatous meningitis.

AFFILIATION: Department of Neurology, University of Washington, Fred Hutchinson Cancer Center, Seattle, Washington.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Myelomatous meningitis Related Publications

• "Accommodating" smoke-free policies: tobacco industry's Courtesy of Choice programme in Latin America.
• Anaplastic astrocytomas: biology and treatment.
• Clean indoor air laws immediately reduce heart attacks.
• Commentary: Assessing the effects of the Scottish Smokefree Law--the placebo effect and the importance of obtaining unbiased data.
• Concentrations of the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in sidestream cigarette smoke increase after release into indoor air: results from unpublished tobacco industry research.
• Depression type in Parkinson disease.
• Effect of smoke-free laws on bar value and profits.
• Eliminating child labour in Malawi: a British American Tobacco corporate responsibility project to sidestep tobacco labour exploitation.
• Endotoxins in tobacco smoke: shifting tobacco industry positions.
• Global leaf companies control the tobacco market in Malawi.
• Implications of the federal court order banning the terms "light" and "mild": what difference could it make?
• It is time to make smokefree environments work in India.
• Keeping genetic secrets.
• Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes.
• Multiple linear regression: accounting for multiple simultaneous determinants of a continuous dependent variable.
• Myelomatous meningitis.
• Old ways, new means: tobacco industry funding of academic and private sector scientists since the Master Settlement Agreement.
• Physician assessment of patient competence.
• Polarization vision in crayfish motion detectors.
• Psychosurgery: the law's response.
• Salvage chemotherapy with CPT-11 for recurrent temozolomide-refractory anaplastic astrocytoma.
• Sidestream cigarette smoke toxicity increases with aging and exposure duration.
• Single-photon emission CT in the evaluation of recurrent brain tumor in patients treated with gamma knife radiosurgery or conventional radiation therapy.
• Smoking in movies and increased smoking among young adults.
• The rise and fall of tobacco control media campaigns, 1967 2006.
• The role of personhood in treatment decisions made by courts.
• The tobacco industry's role in the 16 Cities Study of secondhand tobacco smoke: do the data support the stated conclusions?
• Tobacco industry efforts undermining evidence linking secondhand smoke with cardiovascular disease.
• Tobacco industry sociological programs to influence public beliefs about smoking.
• [A comparative investigation between a simple and a more complicated method to register the retruded position of the mandible on edentulous persons]